Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera®

NCT03061838 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision

Conditions

Rheumatoid Arthritis

Interventions

DRUG: MabThera®
DRUG: Ritumax®

Sponsor

Biointegrator LLC